Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA -0.4EWJ 0.37TECK.B.TO -2.09CNQ.TO 0.71HHL.TO 0.075SYLD 0.03HAC.TO 0.04TRU -0.01
Daily Stock Opinions and Ratings
Stockchase Opinions

Lorne SteinbergBecton DickinsonBDXDON'T BUYJan 31, 2019

They made a huge acquisition a few years ago and took on debt. They are OK financially but they overpaid for the company. He prefers other areas in the Health Care space. It is a big question mark how they integrate this company.
Lorne SteinbergLorne Steinberg
Unknown
Unlock Rating
$249.46

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

BUY

Becton Dickinson(BDX)

Jan 10, 2024

They have incredible reach with 90% of hospital patients touching one of their surgical and medical products

Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
$238.41

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
BUY

Becton Dickinson(BDX)

Sep 20, 2023

Pays a good dividend, is held by institutions, great earnings and has global exposure.

Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
$267.13

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
TOP PICK

Becton Dickinson(BDX)

Aug 04, 2023

Healthcare supplier in North America.
90% of products are disposable - creates recurring revenue.
Expecting double digit earnings growth.
Fantastic M&A growth with good management team.
Dividend growing at a regular pace.

Photo of Lorne SteinbergLorne Steinberg
Owned
Unlock Rating
$272.36

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
WAIT

Becton Dickinson(BDX)

Dec 22, 2021
The company supplies hospitals with medical supplies. 90% of their products are disposable. They have been hurt from COVID as operations have been delayed and it looks that may continue. In a normalized time, they are well situated for an aging population, which should translate into double-digits earnings growth going forward.
Photo of Lorne SteinbergLorne SteinbergUnlock Rating
$247.17

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
BUY

Becton Dickinson(BDX)

Nov 08, 2021
Biggest manufacturer of syringes in the world. It is a large business with multiple moving parts so they have been range bound for the last little while. He likes their opportunities to generate cash flow and so it is a good name to hold.
Photo of Brett Girard, CPA, CA, CFABrett Girard, CPA, CA, CFAUnlock Rating
$245.27

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
HOLD

Becton Dickinson(BDX)

Jul 19, 2021
Big medical supplies. They also have some proprietary parts of the business. He sold it about a month ago to buy one of today's top picks. You won't do too badly owning this going forward.
Photo of Barry SchwartzBarry Schwartz
No
Unlock Rating
$247.25

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
PAST TOP PICK

Becton Dickinson(BDX)

May 27, 2021
(A Top Pick Apr 21/20, Down 4%) Hurt during Covid by surgeries not being performed. Should have a strong 2021.
Photo of Lorne SteinbergLorne Steinberg
Owned
Unlock Rating
$241.70

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
HOLD

Becton Dickinson(BDX)

Mar 29, 2021
He has no plans to sell it. They were very strong last year. It has been a little slow this year. You are not going to have explosive growth every single year. You might want to watch it and buy it if it dips coming out of the pandemic.
Photo of Brett Girard, CPA, CA, CFABrett Girard, CPA, CA, CFA
Owned
Unlock Rating
$247.25

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
WAIT

Becton Dickinson(BDX)

Feb 11, 2021
Syringes, IVs, disposable items. On his hot watch list. He's looking at hospital utilization rates. The market is waiting too. Once rates tick up, they'll be a direct beneficiary.
Photo of Paul MacDonaldPaul MacDonald
No
Unlock Rating
$251.98

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
WATCH

Becton Dickinson(BDX)

Jan 22, 2021
90% of the things they make are disposables. They make syringes among other things. The products are diversified and one does not dominate their revenues. There are many operations that should have happened but have not due to covid. Earnings will accelerate once covid has subsided and procedures restart.
Photo of Lorne SteinbergLorne SteinbergUnlock Rating
$260.49

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
WATCH

Becton Dickinson(BDX)

Jan 22, 2021
90% of the things they make are disposables. They make syringes among other things. The products are diversified and one does not dominate their revenues. There are many operations that should have happened but have not due to covid. Earnings will accelerate once covid has subsided and procedures restart.
Photo of Lorne SteinbergLorne SteinbergUnlock Rating
$260.49

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
TOP PICK

Becton Dickinson(BDX)

Dec 10, 2020

"Canadian Tire" of healthcare products for clinics and medical offices. Products are one-use only. Elective surgeries have been cancelled, so stock has not done much. Will shine in post-Covid era. Yield is 1.38%. (Analysts’ price target is $272.31)

Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$242.34

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
BUY

Becton Dickinson(BDX)

Oct 26, 2020

Healthcare gets knocked down before an election so there is a constant battle at this time of year and then it disappears after the election. This is a great company and continues to do well and you should own it or SYK-N, which he owns.

Photo of Paul Harris, CFAPaul Harris, CFA
No
Unlock Rating
$242.34

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
DON'T BUY

Becton Dickinson(BDX)

Oct 07, 2020

BDX vs. BSX Owns Boston Scientific instead, with a strong history of execution. One-time events threw off that execution. Hospital procedures are coming back, which will benefit the entire industry. BSX is better known for innovation.

Photo of Jennifer RadmanJennifer Radman
No
Unlock Rating
$237.30

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare
BUY

Becton Dickinson(BDX)

Oct 02, 2020
A medical products company. They had a recall of one of their products this year, and they were late on the ball with covid testing. Now that things are open again and people are going to the hospital, they should have a positive outlook.
Photo of Barry SchwartzBarry SchwartzUnlock Rating
$232.66

Stock price when the opinion was issued

$143.96

As of Jun 18, 2026. Market Open.

Healthcare

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV 0$153.3
WSP.TO 1.13$176.7
VRTX 0.47$452.1
OTEX.TO 0.24$29.47
CCO.TO 0.61$151.07
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

NVDA -0.4$210.29
EWJ 0.37$96.63
TECK.B.T… -2.09$88.93
CNQ.TO 0.71$58.66
HHL.TO 0.075$6.865

Popular Articles

Latest Sell Signals

TD.TO 0.7$169.33
MBLY -0.03$8.43
ASAN 0.03$6.95
MODG -0.01$18.21
NVTS 0$24.02

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video